Preclinical Proof-of-Concept Support

Service Offerings: Private Companies

• Content Creation

• Investor Engagement & Strategy

• Industry Insights

___________________________________

Situation

An early-stage biotech needed to generate investor interest in an in-licensed asset that had yet to produce meaningful proof-of-concept data.

Approach

We rebuilt the company’s investor deck to focus on the most compelling aspects of the asset, proposed a targeted preclinical study to deliver validating data, and connected management directly with specialist funds.

Result

By leveraging the updated story and messaging, the company was able to demonstrate a clear proof of concept. Building on that momentum, we facilitated nine introductions to investors in support of their planned private transaction.